Frankfurt - Delayed Quote EUR

Mesa Laboratories, Inc. (MLI.F)

97.50

-6.50

(-6.25%)

As of 8:00:59 AM GMT+2. Market Open.

MESA LABS DECLARES QUARTERLY DIVIDEND

LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control

GlobeNewswire 3 days ago

MLAB
What Makes Mesa Labs (MLAB) a New Strong Buy Stock

Mesa Labs (MLAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks 15 days ago

MLAB
The past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitable

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Simply Wall St. 21 days ago

MLAB
Masimo Corporation (MASI) Hit a 52 Week High, Can the Run Continue?

Masimo (MASI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks last month

MASI

MLAB
Calculating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Key Insights Mesa Laboratories' estimated fair value is US$128 based on 2 Stage Free Cash Flow to Equity Mesa...

Simply Wall St. last month

MLAB
What Makes Mesa Laboratories (MLAB) a Valuable Stock?

Diamond Hill Capital, an investment management company, released its “Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In Q4, markets rose unevenly, ending another positive year for markets. Stocks rose generally after the US election, but several lost most or all of their gains before the end […]

Insider Monkey last month

MLAB

DHIL
Why Mesa Labs (MLAB) Might be Well Poised for a Surge

Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks last month

MLAB

^GSPC
Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 8.98% and 4.91%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

MLAB

GKOS
Mesa Labs: Fiscal Q3 Earnings Snapshot

LAKEWOOD, Colo. AP) — Mesa Laboratories Inc. MLAB) on Tuesday reported a loss of $1.7 million in its fiscal third quarter.

Associated Press Finance 2 months ago

MLAB
Mesa Labs Announces Third Quarter Results

LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q25”) ended December 31, 2024 (amounts in thousands). Third quarter FY 2025 compared to third quarter FY 2024: Revenues increased 17.5%Non-GAAP core organic revenues1 increase was 13.2%Operating income increased 8,725% to $5,779Non-GAAP adjusted

GlobeNewswire 2 months ago

MLAB
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Potentially Undervalued?

Mesa Laboratories, Inc. ( NASDAQ:MLAB ), might not be a large cap stock, but it led the NASDAQGS gainers with a...

Simply Wall St. 3 months ago

MLAB
3 US Stocks Trading Below Estimated Value

As U.S. markets experience a slight pullback following recent record highs, investors are keenly watching how upcoming inflation data might influence Federal Reserve decisions. Amidst this backdrop, identifying stocks trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market fluctuations and economic indicators.

Simply Wall St. 3 months ago

MLAB

SMAR

LPRO
Mesa Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations

Mesa Laboratories ( NASDAQ:MLAB ) Second Quarter 2025 Results Key Financial Results Revenue: US$57.8m (up 8.8% from 2Q...

Simply Wall St. 4 months ago

MLAB
Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -1.21% and 1.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 4 months ago

MLAB
Mesa Labs: Fiscal Q2 Earnings Snapshot

LAKEWOOD, Colo. AP) — Mesa Laboratories Inc. MLAB) on Thursday reported net income of $3.4 million in its fiscal second quarter.

Associated Press Finance 4 months ago

MLAB
Mesa Labs Announces Second Quarter Results

LAKEWOOD, Colo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q25”) ended September 30, 2024 (amounts in thousands). Second quarter FY 2025 compared to second quarter FY 2024: Revenues increased 8.8%Non-GAAP core organic revenues¹ decline was 2.8%Operating income increased 5,947% to $3,508 Non-GAAP adjuste

GlobeNewswire 4 months ago

MLAB
Analysis of Chuck Royce's Recent Transaction in Mesa Laboratories Inc

On September 30, 2024, the investment firm managed by Chuck Royce (Trades, Portfolio) executed a significant transaction involving Mesa Laboratories Inc (NASDAQ:MLAB), a prominent player in the life sciences tools and critical quality control products industry. This move is part of a broader strategy that the firm employs, focusing on value investing and portfolio optimization. Charles M. Royce, a renowned figure in the investment world, has been at the helm of the Royce Pennsylvania Mutual Fund since 1972.

GuruFocus.com 5 months ago

MLAB
Shareholders in Mesa Laboratories (NASDAQ:MLAB) are in the red if they invested three years ago

While not a mind-blowing move, it is good to see that the Mesa Laboratories, Inc. ( NASDAQ:MLAB ) share price has...

Simply Wall St. 5 months ago

MLAB
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 30% Discount?

Key Insights Mesa Laboratories' estimated fair value is US$179 based on 2 Stage Free Cash Flow to Equity Mesa...

Simply Wall St. 6 months ago

MLAB
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks 7 months ago

AXGN

MLAB

Performance Overview

Return	MLI.F	S&P 500 (^GSPC)
YTD	-22.53%	-10.43%
1-Year	+2.65%	+1.33%
3-Year	-56.19%	+19.39%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Mesa Laboratories, Inc. (MLI.F)

MESA LABS DECLARES QUARTERLY DIVIDEND

What Makes Mesa Labs (MLAB) a New Strong Buy Stock

The past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitable

Masimo Corporation (MASI) Hit a 52 Week High, Can the Run Continue?

Calculating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

What Makes Mesa Laboratories (MLAB) a Valuable Stock?

Why Mesa Labs (MLAB) Might be Well Poised for a Surge

Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates

Mesa Labs: Fiscal Q3 Earnings Snapshot

Mesa Labs Announces Third Quarter Results

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Potentially Undervalued?

3 US Stocks Trading Below Estimated Value

Mesa Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations

Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates

Mesa Labs: Fiscal Q2 Earnings Snapshot

Mesa Labs Announces Second Quarter Results

Analysis of Chuck Royce's Recent Transaction in Mesa Laboratories Inc

Shareholders in Mesa Laboratories (NASDAQ:MLAB) are in the red if they invested three years ago

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 30% Discount?

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Performance Overview